SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-21-018495
Filing Date
2021-09-13
Accepted
2021-09-13 17:00:59
Documents
56
Period of Report
2021-07-31

Document Format Files

Seq Description Document Type Size
1 10-Q csbr-20210731.htm   iXBRL 10-Q 796929
2 EX-3.11 csbrq1731202110-qex311.htm EX-3.11 10882
3 EX-3.12 csbrq1731202110-qex312.htm EX-3.12 10982
4 EX-3.21 csbrq1731202110-qex321.htm EX-3.21 8015
  Complete submission text file 0001628280-21-018495.txt   4124620

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT csbr-20210731.xsd EX-101.SCH 27891
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT csbr-20210731_cal.xml EX-101.CAL 48675
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT csbr-20210731_def.xml EX-101.DEF 88423
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT csbr-20210731_lab.xml EX-101.LAB 388216
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT csbr-20210731_pre.xml EX-101.PRE 230345
10 EXTRACTED XBRL INSTANCE DOCUMENT csbr-20210731_htm.xml XML 634689
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Filer) CIK: 0000771856 (see all company filings)

IRS No.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 001-11504 | Film No.: 211250337
SIC: 2836 Biological Products, (No Diagnostic Substances)